FDA — authorised 2 May 1980
- Marketing authorisation holder: ALLERGAN
- Status: approved
FDA authorised Dipivefrin on 2 May 1980
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 2 May 1980.
ALLERGAN holds the US marketing authorisation.